EGFR and cervical cancer: Meira et al. [93] investigated anti-EGFR monoclonal antibodies including cetuximab’s toxicity plus chemoradiation on cervical cancer cells, expressing different EGFR (epidermal growth factor receptor) levels using western blotting and MTT or clonogenic assays.